Glenmark to start trial of favipiravir combo drug for moderate covid-19 symptoms

It will compare the efficacy of the combination drug with that of favipiravir over a 14-day period.Both favipiravir and umifenovir have inhibited virus infection in-vitro

from Livemint - Science https://ift.tt/2ZC6ifz
https://ift.tt/eA8V8J